Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126115652 | 12611565 | 2 | F | 20160517 | 20160913 | 20160801 | 20160916 | PER | US-PFIZER INC-2016334955 | PFIZER | 59.00 | YR | F | Y | 0.00000 | 20160916 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126115652 | 12611565 | 1 | PS | SILDENAFIL CITRATE. | SILDENAFIL CITRATE | 1 | Oral | 50 MG, 2X/DAY | 20895 | 50 | MG | FILM-COATED TABLET | BID | ||||||
| 126115652 | 12611565 | 2 | SS | SILDENAFIL CITRATE. | SILDENAFIL CITRATE | 1 | 20895 | FILM-COATED TABLET | |||||||||||
| 126115652 | 12611565 | 3 | C | JAKAFI | RUXOLITINIB | 1 | 5 MG, UNK | 0 | 5 | MG | TABLET | ||||||||
| 126115652 | 12611565 | 4 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | UNK | 0 | ||||||||||
| 126115652 | 12611565 | 5 | C | AZELAIC ACID. | AZELAIC ACID | 1 | Topical | UNK , 2X/DAY (15%) | 0 | GEL | BID | ||||||||
| 126115652 | 12611565 | 6 | C | BIOTIN | BIOTIN | 1 | Oral | UNK | 0 | ||||||||||
| 126115652 | 12611565 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 1000 IU, DAILY | 0 | 1000 | IU | ||||||||
| 126115652 | 12611565 | 8 | C | COLCHICINE. | COLCHICINE | 1 | 0.6 MG, UNK (2 TABS ONCE THEN ONE TAB 30 MIN LATER) | 0 | .6 | MG | TABLET | ||||||||
| 126115652 | 12611565 | 9 | C | RESTASIS | CYCLOSPORINE | 1 | Ophthalmic | UNK, 2X/DAY (0.05%)(EVERY 12 HOURS) | 0 | BID | |||||||||
| 126115652 | 12611565 | 10 | C | JUBLIA | EFINACONAZOLE | 1 | Topical | UNK (10%) | 0 | ||||||||||
| 126115652 | 12611565 | 11 | C | RECON | 2 | Oral | 5 ML, 4X/DAY (WITH MEALS) | 0 | 5 | ML | QID | ||||||||
| 126115652 | 12611565 | 12 | C | OMEGA-3 FISH OIL +VITAMIN D3 | 2 | Oral | UNK (1000-1000 MG-UNIT) | 0 | CAPSULE | ||||||||||
| 126115652 | 12611565 | 13 | C | HYDROCODONE/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE | 1 | Oral | UNK (1-2 TABS BY MOUTH EVERY 6 HRS) (HYDROCODONE-5MG, ACETAMINOPHEN-300MG) | 0 | TABLET | |||||||||
| 126115652 | 12611565 | 14 | C | HYDREA | HYDROXYUREA | 1 | Oral | 1000 MG, DAILY (ALTERNATING 3 TABS AND 2 TABS QOD) | 0 | 1000 | MG | CAPSULE | |||||||
| 126115652 | 12611565 | 15 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Topical | UNK UNK, DAILY (1%) | 0 | GEL | |||||||||
| 126115652 | 12611565 | 16 | C | MUPIROCIN. | MUPIROCIN | 1 | Topical | UNK UNK, 2X/DAY (2%) | 0 | OINTMENT | BID | ||||||||
| 126115652 | 12611565 | 17 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, DAILY (30 MIN BEFORE BREAKFAST) | 0 | 20 | MG | CAPSULE | |||||||
| 126115652 | 12611565 | 18 | C | PENTOXIFYLLINE. | PENTOXIFYLLINE | 1 | 400 MG, 2X/DAY | 0 | 400 | MG | TABLET | BID | |||||||
| 126115652 | 12611565 | 19 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, DAILY (1 MG TAB/5 TABS BY MOUTH DAILY) | 0 | 5 | MG | TABLET | |||||||
| 126115652 | 12611565 | 20 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 126115652 | 12611565 | 21 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 126115652 | 12611565 | 22 | C | PREDNISONE. | PREDNISONE | 1 | 3 MG, UNK | 0 | 3 | MG | TABLET | ||||||||
| 126115652 | 12611565 | 23 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 20 ML, ALTERNATE DAY (ON MONDAYS, WEDNESDAYS, AND FRIDAYS) | 0 | 20 | ML | QOD | |||||||
| 126115652 | 12611565 | 24 | C | TACROLIMUS. | TACROLIMUS | 1 | Topical | UNK, 2X/DAY (0.1%) | 0 | OINTMENT | BID | ||||||||
| 126115652 | 12611565 | 25 | C | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | Topical | UNK, 2X/DAY (0.1%) | 0 | CREAM | BID | ||||||||
| 126115652 | 12611565 | 26 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126115652 | 12611565 | 1 | Graft versus host disease |
| 126115652 | 12611565 | 2 | Raynaud's phenomenon |
| 126115652 | 12611565 | 3 | Graft versus host disease |
| 126115652 | 12611565 | 5 | Rash |
| 126115652 | 12611565 | 8 | Gout |
| 126115652 | 12611565 | 10 | Nail disorder |
| 126115652 | 12611565 | 15 | Rosacea |
| 126115652 | 12611565 | 19 | Urticaria |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126115652 | 12611565 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126115652 | 12611565 | 1 | 20160517 | 0 | ||
| 126115652 | 12611565 | 3 | 20160517 | 0 |